1. null
    Andréia Cristina Karklin Fontana, 2018 CrossRef
  2. Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study
    David J. Valent et al, 2018, Trans. Vis. Sci. Tech. CrossRef
  3. null
    Jeff Victoroff, 2019 CrossRef
  4. Desferrioxamine and dextromethorphan combination exhibited synergistic effect and reversed the catalepsy behaviour in 6‐hydroxydopamine hydroydopamine administered rats through regulating brain glutamate levels
    Navaf Mannan Thodukayil et al, 2019, J Pharm Pharmacol CrossRef
  5. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
    Linda Nguyen et al, 2016, Pharmacology & Therapeutics CrossRef
  6. The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
    Cheng-Tsung Liu et al, 2019, European Journal of Pharmacology CrossRef
  7. Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury
    Emmanuelle Simon-O’Brien et al, 2016, J Neuroinflammation CrossRef
  8. Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids
    Angela Maria Amorini et al, 2017, J. Cell. Mol. Med. CrossRef
  9. Naringin provides neuroprotection in CCL2-induced cognition impairment by attenuating neuronal apoptosis in the hippocampus
    Jiang-yi Long et al, 2020, Behav Brain Funct CrossRef
  10. Dextromethorphan Suppresses Lipopolysaccharide-Induced Epigenetic Histone Regulation in the Tumor Necrosis Factor-α Expression in Primary Rat Microglia
    Yung-Ning Yang et al, 2020, Mediators of Inflammation CrossRef
  11. A review on neurodevelopmental abnormalities in congenital heart disease: focus on minimizing the deleterious effects on patients
    Bai-hong Zheng et al, 2021, All Life CrossRef
  12. Restoration of Sarco/Endoplasmic Reticulum Ca2+-ATPase Activity Functions as a Pivotal Therapeutic Target of Anti-Glutamate-Induced Excitotoxicity to Attenuate Endoplasmic Reticulum Ca2+ Depletion
    Wen Zhang et al, 2022, Front. Pharmacol. CrossRef
  13. The Time Sequence of Gene Expression Changes after Spinal Cord Injury
    Seyoung Mun et al, 2022, Cells CrossRef
  14. The use of ketamine as a neuroprotective agent following cardiac arrest: A scoping review of current literature
    Marlena Ornowska et al, 2022, CNS Neurosci Ther CrossRef
  15. Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
    Edward Pajarillo et al, 2022, Front. Pharmacol. CrossRef
  16. Glutamatergic Neurotransmission: A Potential Pharmacotherapeutic Target for the Treatment of Cognitive Disorders
    Pratik Chakraborty et al, 2023, Ageing Research Reviews CrossRef
  17. The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice
    Laura Wörmeyer et al, 2024, Horm Metab Res CrossRef